Skip to content

Clinical trials

Autism Spectrum Disorder trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autism Spectrum Disorder Country / region: France Clear all

107 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20092
20111
20125
20136
20143
20156
20164
20171
20186
20194
20206
20217
20228
202317
202410
20256
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Recruiting30
Unknown status20
Not yet recruiting14
Terminated6
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris16
University Hospital, Montpellier10
Hôpital le Vinatier8
University Hospital, Strasbourg, France8
Institut National de la Santé Et de la Recherche Médicale, France7
University Hospital, Tours5
University Hospital, Grenoble4
Centre Hospitalier St Anne3
Forest Laboratories3
Hospices Civils de Lyon3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autism Spectrum Disorder107
Autistic Disorder19
Neurodevelopmental Disorders7
Intellectual Disability6
Schizophrenia5
Attention Deficit Disorder with Hyperactivity4
Asperger Syndrome3
Bipolar Disorder3
Disease2
Major Depressive Disorder2

Trials

Showing 51 to 75 of 107. Each trial links to its page on Pharma Observatory.

7 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.